Cargando…

Editorial: Tumor adaptation to cellular stresses: mechanisms, biomarkers and therapeutic opportunities

Detalles Bibliográficos
Autores principales:	Cortesi, Michela, Rossino, Giacomo, Chakrabarty, Anindita, Rossi, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470628/ https://www.ncbi.nlm.nih.gov/pubmed/37663659 http://dx.doi.org/10.3389/fmed.2023.1268976

Ejemplares similares

Repurposing the Antiplatelet Agent Ticlopidine to Counteract the Acute Phase of ER Stress Condition: An Opportunity for Fighting Coronavirus Infections and Cancer
por: Tesei, Anna, et al.
Publicado: (2022)

Editorial: Cellular stress in blood cancer: Pathophysiology and therapeutic opportunities
por: Costoya, José A., et al.
Publicado: (2022)

Editorial: Therapeutic Opportunities and Innovative Biomarkers in Tumor Microenvironment
por: Xu, Kexin, et al.
Publicado: (2021)

Editorial: Molecular biomarkers in hepatobiliary and pancreatic cancers: implications of non-coding RNAs and its therapeutic opportunities
por: Roy, Souvick, et al.
Publicado: (2023)

Editorial: Aldehyde dehydrogenase in clinical settings: Potential biomarker and therapeutic target in solid tumors
por: Aramini, Beatrice, et al.
Publicado: (2023)

Editorial: Cellular Senescence: Causes, Consequences and Therapeutic Opportunities
por: Wong, Pooi-Fong
Publicado: (2022)

Peptides as Therapeutic Agents: Challenges and Opportunities in the Green Transition Era
por: Rossino, Giacomo, et al.
Publicado: (2023)

Editorial: Organ Fibrosis: Pathogenesis, Biomarkers and Therapeutic Targets
por: Mutsaers, Henricus A. M., et al.
Publicado: (2021)

Editorial: Opportunities and Challenges of Digitization in Rheumatology
por: Sewerin, Philipp
Publicado: (2022)

Editorial: Loss of Epithelial Barrier Integrity in Inflammatory Diseases: Cellular Mediators and Therapeutic Targets
por: Weidinger, Carl, et al.
Publicado: (2021)

Editorial: The role of novel hepatitis B biomarkers in solving therapeutic dilemmas
por: Lazarevic, Ivana, et al.
Publicado: (2023)

Editorial: Molecular and cellular mechanisms of heart failure: pathophysiology, pathogenesis and therapeutics
por: Lal, Sean, et al.
Publicado: (2023)

Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents
por: Listro, Roberta, et al.
Publicado: (2020)

Editorial: Profiling the tumour microenvironment to unveil biomarkers and develop novel therapeutics for cancer therapy
por: Jaillon, Sebastien, et al.
Publicado: (2023)

Editorial: Biomarkers in CKD
por: Araujo, Magali, et al.
Publicado: (2017)

Editorial: Inflammation and Biomarkers in Osteoarthritis
por: Mobasheri, Ali, et al.
Publicado: (2021)

Editorial: Biomarkers in Pulmonary Diseases
por: Mahboub, Bassam, et al.
Publicado: (2022)

RFID analysis of the complexity of cellular pathology workflow—An opportunity for digital pathology
por: Browning, Lisa, et al.
Publicado: (2022)

Editorial: Organ Fibrosis: Triggers, Pathways, and Cellular Plasticity
por: Mutsaers, Henricus A. M., et al.
Publicado: (2016)

Sigma-1 Receptor Agonists Acting on Aquaporin-Mediated H(2)O(2) Permeability: New Tools for Counteracting Oxidative Stress
por: Pellavio, Giorgia, et al.
Publicado: (2021)

Editorial: Cardiac Tumors: A Challenge in Diagnosis and Therapeutic Approach
por: Lestuzzi, Chiara
Publicado: (2022)

Editorial: Resistance to Endocrine Therapies in Cancer
por: Ranganathan, Prathibha, et al.
Publicado: (2020)

Editorial: Tumor Heterogeneity
por: La Rosa, Stefano, et al.
Publicado: (2019)

Editorial: Updates in ocular therapeutics and surgery
por: Panos, Georgios D., et al.
Publicado: (2023)

Editorial: State of the art, opportunities and challenges in the use of medical detection dogs in the laboratory and in the field
por: Volk, Holger A., et al.
Publicado: (2023)

Editorial: Omics biomarkers in inflammatory ocular diseases
por: Ttakeuchi, Masaru, et al.
Publicado: (2022)

Editorial: Thrombotic Microangiopathies, Diagnostic and Therapeutic Advances
por: Maitta, Robert W., et al.
Publicado: (2021)

Editorial: Therapeutic Advancements in Psoriasis and Psoriatic Arthritis
por: Panda, Saumya
Publicado: (2022)

Editorial: Next Therapeutic Targets in Ocular Diseases
por: Yanai, Ryoji, et al.
Publicado: (2022)

RAS-mediated tumor stress adaptation and the targeting opportunities it presents
por: Redding, Alexandra, et al.
Publicado: (2022)

Editorial: Abdominal aortic aneurysms: advancements in diagnosis, biomarkers, drug therapeutics, surgical and endovascular treatment
por: Liu, Zhenjie
Publicado: (2023)

Editorial: Insights Into Biomarkers, Cytokines, and Chemokines in Skin Cancer
por: Barrett, Lucy W., et al.
Publicado: (2019)

Editorial: Recent advances and new biomarkers in ulcerative colitis
por: Velikova, Tsvetelina, et al.
Publicado: (2023)

Editorial: Update on diagnostic and prognostic biomarkers for women's cancers
por: Zhu, Yunxia, et al.
Publicado: (2023)

Editorial: Torquetenovirus: predictive biomarker or innocent bystander in pathogenesis
por: Tozetto-Mendoza, Tania Regina, et al.
Publicado: (2023)

Editorial: Cardiovascular adaptation to extreme environment
por: Pingitore, Alessandro, et al.
Publicado: (2022)

Editorial: Pathogenic Advances and Therapeutic Perspectives for Eosinophilic Inflammation
por: Roufosse, Florence E., et al.
Publicado: (2018)

Editorial: Comorbidities in Psoriatic Arthritis and Their Impact on Therapeutic Strategies
por: Pantano, Ilenia, et al.
Publicado: (2022)

Editorial: Women in cardiovascular therapeutics
por: Yin, Liya, et al.
Publicado: (2023)

PEG 400/Cerium Ammonium Nitrate Combined with Microwave-Assisted Synthesis for Rapid Access to Beta-Amino Ketones. An Easy-to-Use Protocol for Discovering New Hit Compounds
por: Rossino, Giacomo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c0rc334kpmolcto4g7o67m0vpq